Amy Gosnell, MD
Dermatology · Westerville, OHNPI 1326283698
Payments from drug & device makers
Across 229 payments — averaging $18.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Regeneron Healthcare Solutions, Inc.$444
- Johnson & Johnson$295
- Pfizer$286
- UCB, Inc.$212
- Boehringer Ingelheim$186
- plus $2K from 21 others
What the payments were for
- Food & beverage$4,13999%
- Education$381%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 71 | $1,221 |
| Regeneron Healthcare Solutions, Inc. | 25 | $444 |
| Johnson & Johnson | 14 | $295 |
| Pfizer | 17 | $286 |
| UCB, Inc. | 9 | $212 |
| Boehringer Ingelheim | 8 | $186 |
| E.r. Squibb & Sons, L.L.C. | 7 | $156 |
| Lilly USA, LLC | 8 | $147 |
| Sun Pharmaceutical Industries Inc. | 8 | $142 |
| Novartis | 9 | $141 |
| Sanofi | 6 | $137 |
| Galderma Laboratories, L.p. | 7 | $114 |
| Incyte Corporation | 5 | $101 |
| Arcutis Biotherapeutics, Inc. | 5 | $94 |
| Dermavant Sciences, Inc. | 5 | $84 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $81 |
| Organon | 4 | $61 |
| Amgen | 3 | $57 |
| Almirall LLC | 2 | $44 |
| Kyowa Kirin, Inc. | 2 | $41 |
| Prugen, Inc. Pharmaceuticals | 3 | $29 |
| Dermira, Inc. | 2 | $25 |
| Mayne Pharma Commercial LLC | 1 | $18 |
| Organogenesis Inc. | 1 | $16 |
| LEO Pharma Inc. | 1 | $16 |
| Bristol Myers Squibb | 1 | $15 |
| Krystal Biotech Inc | 1 | $14 |
How this compares
$4,177 in reported general payments places this provider in the 60th percentile of 460 dermatology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 124 | $1,807 |
| Metronidazole | 23 | $980 |
| Tacrolimus | 12 | $851 |
| Clobetasol Propionate | 22 | $667 |
| Fluocinonide | 24 | $656 |
| Doxycycline Hyclate | 20 | $462 |
| ValacyclovirValacyclovir Hcl | 22 | $364 |
| Hydroxychloroquine Sulfate | 16 | $162 |
| Triamcinolone Acetonide | 37 | $133 |
| Ciclopirox | 16 | $70 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Westerville
- Jennifer NashWesterville$4M
- Jess DemariaWesterville$813K
- Joshua GrosshandlerWesterville$479K
- Kevin DonnellyWesterville$353K
- Matthew ZirwasBexley$7.4M
- Neil KormanCleveland$6M
- Jeffrey TraversDayton$4.7M
- Jessica KaffenbergerColumbus$3.2M
- Rocco SerraoDayton$3M
- Patrick ShannonBoardman$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.